Literature DB >> 15820328

Change in the relationship between anhedonia and functional deficits over a 20-year period in individuals with schizophrenia.

Ellen S Herbener1, Martin Harrow, S Kristian Hill.   

Abstract

Although early theorists suggested that deficits in emotional experience be considered a hallmark characteristic of schizophrenia, there has been limited research, and inconsistent findings, on the relationship between anhedonia and functional capacity in individuals after the onset of schizophrenia. Stronger relationships have typically been reported for chronic samples in contrast to first episode samples, although it is not clear whether this is due to selection biases that influence recruitment in these different groups, or whether results reflect a change over the course of illness. The current longitudinal study examined the relationship between physical anhedonia and functional status in a sample of 61 individuals with schizophrenia at regular intervals over a 20-year period. Subjects were recruited into the study during an index hospitalization and completed assessments at 2-, 4.5-, 7.5-, 10-, 15-, and 20-year follow-ups. Analyses indicate that the relationship between anhedonia and impairments increases over time, although mean performance on these measures is stable across this same time period. These results suggest increasing convergence of impairments in emotional, adaptive, and cognitive capacities over time, with physical anhedonia associated with poorer outcome.

Entities:  

Mesh:

Year:  2005        PMID: 15820328     DOI: 10.1016/j.schres.2004.12.013

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  28 in total

Review 1.  Goal representations and motivational drive in schizophrenia: the role of prefrontal-striatal interactions.

Authors:  Deanna M Barch; Erin C Dowd
Journal:  Schizophr Bull       Date:  2010-06-21       Impact factor: 9.306

Review 2.  Anhedonia in schizophrenia.

Authors:  Daniel H Wolf
Journal:  Curr Psychiatry Rep       Date:  2006-08       Impact factor: 5.285

3.  Neurophysiological differences in reward processing in anhedonics.

Authors:  Gonçalo Padrão; Aida Mallorquí; David Cucurell; Josep Marco-Pallares; Antoni Rodriguez-Fornells
Journal:  Cogn Affect Behav Neurosci       Date:  2013-03       Impact factor: 3.282

4.  Odor hedonic capacity and anhedonia in schizophrenia and unaffected first-degree relatives of schizophrenia patients.

Authors:  Vidyulata Kamath; Paul J Moberg; Christian G Kohler; Raquel E Gur; Bruce I Turetsky
Journal:  Schizophr Bull       Date:  2011-05-26       Impact factor: 9.306

5.  A psychophysiological investigation of threat and reward sensitivity in individuals with panic disorder and/or major depressive disorder.

Authors:  Stewart A Shankman; Brady D Nelson; Casey Sarapas; E Jenna Robison-Andrew; Miranda L Campbell; Sarah E Altman; Sarah Kate McGowan; Andrea C Katz; Stephanie M Gorka
Journal:  J Abnorm Psychol       Date:  2012-11-12

6.  Associations between trait anhedonia and emotional memory deficits in females with schizophrenia versus major depression.

Authors:  Emily K Olsen; Olivia A Bjorkquist; Anjuli S Bodapati; Stewart A Shankman; Ellen S Herbener
Journal:  Psychiatry Res       Date:  2015-09-09       Impact factor: 3.222

7.  Anhedonia and emotional experience in schizophrenia: neural and behavioral indicators.

Authors:  Erin C Dowd; Deanna M Barch
Journal:  Biol Psychiatry       Date:  2009-12-09       Impact factor: 13.382

Review 8.  Affective traits in schizophrenia and schizotypy.

Authors:  William P Horan; Jack J Blanchard; Lee Anna Clark; Michael F Green
Journal:  Schizophr Bull       Date:  2008-07-29       Impact factor: 9.306

9.  Emotional experience predicts social adjustment independent of neurocognition and social cognition in schizophrenia.

Authors:  Ivy F Tso; Tyler B Grove; Stephan F Taylor
Journal:  Schizophr Res       Date:  2010-01-03       Impact factor: 4.939

Review 10.  Turning it upside down: areas of preserved cognitive function in schizophrenia.

Authors:  James M Gold; Britta Hahn; Gregory P Strauss; James A Waltz
Journal:  Neuropsychol Rev       Date:  2009-05-19       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.